Then it made more sense to me to try and build some evidence for that
It is used alongside a low-calorie diet and added physical activity
[DOI] [PubMed] [Google Scholar] 96.Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, et al
although the risk was increased with concomitant SU therapy [11]
Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease
00:18:58 Narrator Weve linked the resources we mentioned and more on todays topic right in the show notes